Similarly, the tumour suppressive activity of maspin has been demonstrated for prostate cancer (Umekita et al, 1997), oral carcinoma (Xia et al, 2000), and colon cancer (Song et al, 2002). The gene discussed is SERPINB5; the disease is malignant colon neoplasm.